Sean C Skeldon1, Allan S Detsky2, S Larry Goldenberg3, Michael R Law4. 1. The Centre for Health Services and Policy Research, School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada Department of Urological Sciences, The University of British Columbia, Vancouver, British Columbia, Canada sean.skeldon@ubc.ca. 2. The Institute of Health Policy, Management and Evaluation, and Department of Medicine, University of Toronto, and the Department of Medicine, Mount Sinai Hospital and University Health Network, Toronto, Ontario, Canada. 3. Department of Urological Sciences, The University of British Columbia, Vancouver, British Columbia, Canada. 4. The Centre for Health Services and Policy Research, School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
PURPOSE: We investigated whether erectile dysfunction, a marker for future cardiovascular disease, is associated with undiagnosed cardiometabolic risk factors among US men. Identifying the presence of these risk factors could lead to earlier initiation of treatment for primary prevention of cardiovascular disease. METHODS: We analyzed cross-sectional data from men aged 20 years and older who participated in the National Health and Nutrition Examination Survey during 2001-2004. Erectile dysfunction was determined by a single, validated survey question. We used logistic regression analyses to investigate the relationship between erectile dysfunction and undiagnosed hypertension, hypercholesterolemia, and diabetes. RESULTS: After multivariate adjustment, men with erectile dysfunction had more than double the odds of having undiagnosed diabetes (odds ratio = 2.20; 95% CI, 1.10-4.37), whereas no association was seen for undiagnosed hypertension or undiagnosed hypercholesterolemia. For the average man aged 40 to 59 years, the predicted probability of having undiagnosed diabetes increased from 1 in 50 in the absence of erectile dysfunction to 1 in 10 in the presence of erectile dysfunction. CONCLUSIONS: Our results underscore the importance of erectile dysfunction as a marker of undiagnosed diabetes. Erectile dysfunction should be a trigger to initiate diabetes screening, particularly among middle-aged men.
PURPOSE: We investigated whether erectile dysfunction, a marker for future cardiovascular disease, is associated with undiagnosed cardiometabolic risk factors among US men. Identifying the presence of these risk factors could lead to earlier initiation of treatment for primary prevention of cardiovascular disease. METHODS: We analyzed cross-sectional data from men aged 20 years and older who participated in the National Health and Nutrition Examination Survey during 2001-2004. Erectile dysfunction was determined by a single, validated survey question. We used logistic regression analyses to investigate the relationship between erectile dysfunction and undiagnosed hypertension, hypercholesterolemia, and diabetes. RESULTS: After multivariate adjustment, men with erectile dysfunction had more than double the odds of having undiagnosed diabetes (odds ratio = 2.20; 95% CI, 1.10-4.37), whereas no association was seen for undiagnosed hypertension or undiagnosed hypercholesterolemia. For the average man aged 40 to 59 years, the predicted probability of having undiagnosed diabetes increased from 1 in 50 in the absence of erectile dysfunction to 1 in 10 in the presence of erectile dysfunction. CONCLUSIONS: Our results underscore the importance of erectile dysfunction as a marker of undiagnosed diabetes. Erectile dysfunction should be a trigger to initiate diabetes screening, particularly among middle-aged men.
Keywords:
cardiovascular disease; disease prevention; health promotion; men; reproductive system; risk factors; screening; sexual function; special population
Authors: Lester R Curtin; Leyla K Mohadjer; Sylvia M Dohrmann; Jill M Montaquila; Deanna Kruszan-Moran; Lisa B Mirel; Margaret D Carroll; Rosemarie Hirsch; Susan Schober; Clifford L Johnson Journal: Vital Health Stat 2 Date: 2012-05
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2012-12-12 Impact factor: 29.690
Authors: Clifford L Johnson; Ryne Paulose-Ram; Cynthia L Ogden; Margaret D Carroll; Deanna Kruszon-Moran; Sylvia M Dohrmann; Lester R Curtin Journal: Vital Health Stat 2 Date: 2013-09
Authors: Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen Journal: Mayo Clin Proc Date: 2009-02 Impact factor: 7.616
Authors: Heejung Bang; Alison M Edwards; Andrew S Bomback; Christie M Ballantyne; David Brillon; Mark A Callahan; Steven M Teutsch; Alvin I Mushlin; Lisa M Kern Journal: Ann Intern Med Date: 2009-12-01 Impact factor: 25.391
Authors: Shakeel Ahmed Memon; Muhammad Adil; Fahad Raja Khan; Safi Ullah; Samra Rehmat; Nooh Zad Gul Journal: Int J Cardiol Heart Vasc Date: 2022-04-18
Authors: Irwin Goldstein; Annamaria Giraldi; Martine C Maculaitis; Vicky W Li; Rose Hartzell-Cushanick; Tarek A Hassan Journal: Sex Med Date: 2020-06-27 Impact factor: 2.491
Authors: Lauren J Lee; Terence A Maguire; Martine C Maculaitis; Birol Emir; Vicky W Li; Mara Jeffress; Jim Z Li; Kelly H Zou; Shaantanu S Donde; David Taylor Journal: Int J Clin Pract Date: 2020-12-05 Impact factor: 2.503